15-55467043-AT-ATT

Variant summary

Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong

The NM_130810.4(DNAAF4):​c.523dupA​(p.Ile175AsnfsTer15) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000639 in 1,548,996 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.

Frequency

Genomes: 𝑓 0.000033 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000067 ( 0 hom. )

Consequence

DNAAF4
NM_130810.4 frameshift

Scores

Not classified

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:4

Conservation

PhyloP100: 0.645
Variant links:
Genes affected
DNAAF4 (HGNC:21493): (dynein axonemal assembly factor 4) This gene encodes a tetratricopeptide repeat domain-containing protein. The encoded protein interacts with estrogen receptors and the heat shock proteins, Hsp70 and Hsp90. An homologous protein in rat has been shown to function in neuronal migration in the developing neocortex. A chromosomal translocation involving this gene is associated with a susceptibility to developmental dyslexia. Mutations in this gene are associated with deficits in reading and spelling. Alternative splicing results in multiple transcript variants. Read-through transcription also exists between this gene and the downstream cell cycle progression 1 (CCPG1) gene. [provided by RefSeq, Mar 2011]
DNAAF4-CCPG1 (HGNC:43019): (DNAAF4-CCPG1 readthrough (NMD candidate)) This locus represents naturally occurring read-through transcription between the neighboring dyslexia susceptibility 1 candidate 1 (DYX1C1) and cell cycle progression 1 (CCPG1) genes on chromosome 15. The read-through transcript is a candidate for nonsense-mediated mRNA decay (NMD), and is thus unlikely to produce a protein product. [provided by RefSeq, Mar 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 18 ACMG points.

PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 15-55467043-A-AT is Pathogenic according to our data. Variant chr15-55467043-A-AT is described in ClinVar as [Likely_pathogenic]. Clinvar id is 496919.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DNAAF4NM_130810.4 linkc.523dupA p.Ile175AsnfsTer15 frameshift_variant Exon 5 of 10 ENST00000321149.7 NP_570722.2 Q8WXU2-1
DNAAF4NM_001033560.2 linkc.523dupA p.Ile175AsnfsTer15 frameshift_variant Exon 5 of 9 NP_001028732.1 Q8WXU2-2A0A0S2Z5Z4
DNAAF4NM_001033559.3 linkc.523dupA p.Ile175AsnfsTer15 frameshift_variant Exon 5 of 9 NP_001028731.1 Q8WXU2-3
DNAAF4-CCPG1NR_037923.1 linkn.778dupA non_coding_transcript_exon_variant Exon 4 of 16

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DNAAF4ENST00000321149.7 linkc.523dupA p.Ile175AsnfsTer15 frameshift_variant Exon 5 of 10 1 NM_130810.4 ENSP00000323275.3 Q8WXU2-1

Frequencies

GnomAD3 genomes
AF:
0.0000333
AC:
5
AN:
150034
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000245
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000593
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.0000672
AC:
94
AN:
1398962
Hom.:
0
Cov.:
32
AF XY:
0.0000737
AC XY:
51
AN XY:
692128
show subpopulations
Gnomad4 AFR exome
AF:
0.0000655
Gnomad4 AMR exome
AF:
0.000170
Gnomad4 ASJ exome
AF:
0.0000399
Gnomad4 EAS exome
AF:
0.0000555
Gnomad4 SAS exome
AF:
0.000142
Gnomad4 FIN exome
AF:
0.0000199
Gnomad4 NFE exome
AF:
0.0000629
Gnomad4 OTH exome
AF:
0.0000520
GnomAD4 genome
AF:
0.0000333
AC:
5
AN:
150034
Hom.:
0
Cov.:
32
AF XY:
0.0000410
AC XY:
3
AN XY:
73186
show subpopulations
Gnomad4 AFR
AF:
0.0000245
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000593
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.0000642

ClinVar

Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Pathogenic:2
Nov 28, 2016
Eurofins Ntd Llc (ga)
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jul 23, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This sequence change creates a premature translational stop signal (p.Ile175Asnfs*15) in the DNAAF4 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DNAAF4 are known to be pathogenic (PMID: 23872636). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with DNAAF4-related conditions. ClinVar contains an entry for this variant (Variation ID: 496919). For these reasons, this variant has been classified as Pathogenic. -

Primary ciliary dyskinesia 25 Pathogenic:1
Oct 14, 2022
Laboratorio de Genetica e Diagnostico Molecular, Hospital Israelita Albert Einstein
Significance: Likely pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

ACMG classification criteria: PVS1 very strong, PM2 supporting -

DNAAF4-related disorder Pathogenic:1
Aug 21, 2023
PreventionGenetics, part of Exact Sciences
Significance: Likely pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The DNAAF4 c.523dupA variant is predicted to result in a frameshift and premature protein termination (p.Ile175Asnfs*15). To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.025% of alleles in individuals of Ashkenazi Jewish descent in gnomAD (http://gnomad.broadinstitute.org/variant/15-55759241-A-AT). Frameshift variants in DNAAF4 are expected to be pathogenic. This variant is interpreted as likely pathogenic. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs751610886; hg19: chr15-55759241; API